Outbreaks of Filovirus Hemorrhagic Fever: Time to Refocus on the Patient
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 196 (s2) , S136-S141
- https://doi.org/10.1086/520542
Abstract
In the 40 years since the recognition of filoviruses as agents of lethal human disease, there have been no specific advances in antiviral therapies oKeywords
This publication has 19 references indexed in Scilit:
- A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialClinical and Vaccine Immunology, 2006
- Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant VaccineJournal of Virology, 2006
- Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA InterferenceThe Journal of Infectious Diseases, 2006
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesNature Medicine, 2005
- Billions for Biodefense: Federal Agency Biodefense Budgeting, FY2005–FY2006Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2005
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeysThe Lancet, 2003
- Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primatesNature, 2003
- Ebola outbreak in the newsThe Lancet Infectious Diseases, 2003
- Pre- and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human AntibodyJournal of Virology, 2002
- Development of a preventive vaccine for Ebola virus infection in primatesNature, 2000